pyrvinium has been researched along with Medulloblastoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hadden, MK; Wen, J | 1 |
| Bai, F; Baubet, V; Capobianco, AJ; Dahmane, N; Fei, DL; Flaveny, CA; Han, L; Hang, B; Lee, E; Li, B; Orton, D; Pei, XH; Robbins, DJ; Rodriguez-Blanco, J; Wang, B; Wang, Z | 1 |
1 review(s) available for pyrvinium and Medulloblastoma
| Article | Year |
|---|---|
Medulloblastoma drugs in development: Current leads, trials and drawbacks.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cerebellar Neoplasms; Humans; Medulloblastoma; Protein Kinase Inhibitors | 2021 |
1 other study(ies) available for pyrvinium and Medulloblastoma
| Article | Year |
|---|---|
Pyrvinium attenuates Hedgehog signaling downstream of smoothened.
Topics: Animals; Carcinoma, Basal Cell; Casein Kinase Ialpha; Cell Line; Hedgehog Proteins; HEK293 Cells; Humans; Medulloblastoma; Mice; Mice, Nude; NIH 3T3 Cells; Oncogene Proteins; Pyrvinium Compounds; Receptors, G-Protein-Coupled; Signal Transduction; Trans-Activators; Transcription Factors; Zinc Finger Protein GLI1 | 2014 |